Cost-effectiveness of homocysteine-lowering therapy to prevent coronary heart disease.
Sunder-Plassmann
Gere
G
Födinger
Manuela
M
D003324:Coronary Artery Disease / Q000191:economics / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D019587:Dietary Supplements / Q000191:economics; D005492:Folic Acid / Q000627:therapeutic use; D006710:Homocysteine / Q000097:blood; D006801:Humans; D014815:Vitamins / Q000627:therapeutic use*
D014815:Vitamins; D006710:Homocysteine; D005492:Folic Acid